Global Information
회사소개 | 문의 | 비교리스트

세계의 의료 수탁연구 시장 조사와 예측

Global Healthcare Contract Research Market Research and Forecast, 2019-2025

리서치사 Orion Market Research Pvt Ltd
발행일 2019년 05월 상품 코드 839588
페이지 정보 영문
가격
US $ 3,600 ₩ 4,329,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,772,000 Printable PDF (Enterprise License)


세계의 의료 수탁연구 시장 조사와 예측 Global Healthcare Contract Research Market Research and Forecast, 2019-2025
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의료 수탁연구(Healthcare Contract Research) 시장에 주목하여 그 전체상과 발전성을 살필 수 있도록 거래 규모 예측 수치를 시장 부문 및 지역별로 나타내 보이고, 경제 전반을 배경으로 한 발전 촉진요인 및 억제요인, 기회 등 직접 취재 및 2차 정보 조사와 분석을 통해 얻어진 팩트, 시장 진출기업의 사업 추진과 경쟁 구도에 관한 최신 조사 정보를 제공합니다.

제1장 보고서 요약

  • 조사 방법과 수단
  • 시장 분석
    • 부문별
    • 지역별
    • 이해관계자별

제2장 시장 개요와 인사이트

  • 정의
  • 애널리스트 인사이트 및 현재 시장 동향
    • 중요 소견
    • 제안
    • 결론
  • 규정 및 규제

제3장 경쟁 환경

  • 경쟁 대시보드
  • 주요 전략 분석
  • 주요 기업 분석

제4장 시장 결정요인

  • 성장 촉진요인
  • 성장 저해요인
  • 발전 기회

제5장 시장 세분화

  • 세계의 의료 수탁연구 시장 : 서비스별
    • Drug Discovery & Development
    • 전임상 서비스
    • 임상 서비스
    • 위험 관리 및 시판 후 의약품 안전성 감시
    • 데이터 관리 및 기술 서비스
    • 시판 후 및 컨설팅 서비스
    • 기타 서비스(실험실 서비스, 프로젝트 관리 등)
  • 세계의 의료 수탁연구 시장 : 치료 분야별
    • 심장병학
    • 암치료
    • 신경학
    • 호흡기질환
    • 자가면역질환
    • 기타(혈액학, 부인과 등)

제6장 지역별 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 기타 지역

제7장 기업 개요

  • Charles River Laboratories International Inc.(CRL)
  • Clinipace, Inc.
  • Fisher Clinical Services, Inc.
  • GVK Biosciences Pvt., Ltd.
  • HCL Technologies, Ltd.
  • ICON, PLC
  • IQVIA Holdings, Inc.
  • JLL Partners, LLC
  • LabCorp(Covance)
  • Lambda Therapeutic Research, Ltd.
  • Medelis, Inc.
  • Medpace, Inc.
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC
  • Pharmaron Beijing Co., Ltd.
  • PRA Health Sciences, Inc.
  • Premier Research International, LLC
  • QPS Holdings, LLC
  • Syneos Health, Inc.
  • Synteract, Inc.
  • Worldwide Clinical Trials Holdings, Inc.
LSH 19.05.29

List of Tables

  • 1. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 2. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PRE-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL RISK MANAGEMENT & PHARMACOVIGILANCE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL DATA MANAGEMENT & TECHNOLOGY SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL POST MARKETING & CONSULTING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL OTHER SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS AREA, 2018-2025 ($ MILLION)
  • 10. GLOBAL CARDIOVASCULAR DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL AUTOIMMUNE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL RESPIRATORY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL ONCOLOGY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL NEUROLOGY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL OTHER DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 20. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 21. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 22. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 23. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 26. REST OF THE WORLD HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 27. REST OF THE WORLD HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL HEALTHCARE CRO MARKET SHARE BY SERVICE, 2018 VS 2025 (%)
  • 2. GLOBAL HEALTHCARE CRO MARKET SHARE BY THERAPEUTIC AREA, 2018 VS 2025 (%)
  • 3. GLOBAL HEALTHCARE CRO MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. REST OF EUROPE HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)

Global Healthcare Contract Research Organizations (CRO) Market, Size, Share & Trends Analysis Report, By Services (Drug Discovery & Development, Pre-Clinical Services, Clinical Services, Risk Management & Pharmacovigilance, and Others Services), By Therapeutic Area (Cardiology, Autoimmune Diseases, Oncology, Neurology, Respiratory Diseases and Others) and Forecast, 2019-2025

Healthcare CRO market has significant scope in pharmaceutical, biotechnology, and medical device industry since it reduces cost and time for clinical trial and drug development. CROs offers capabilities, for the growth of drug development, which includes pre-clinical R&D, clinical trials, monitoring and management, data management and analysis, study design, bio-statistical analysis, post-marketing surveillance, consulting, regulatory and safety assessment, and other services. The pharmaceutical companies, increasingly outsourcing critical functions, such as manufacturing and research. Use of CROs to lead clinical trials and develop new medications has been increased over the years.

Moreover, the major factors that are contributing towards the growth of the healthcare CRO market include rising demand for CRO, from pharmaceutical, biopharmaceutical, and medical device industries. Additionally, increasing outsourcing of R&D programs, rising R&D expenditures and growing number of clinical trials will drive the healthcare CRO market in near future. The CRO collaborations with government agencies and non-profit health organizations allows to expand clinical service providers, new drug development process and offers advanced healthcare outcomes. The CRO is considered as more affordable for companies to track new medications, however, pre-pursuing a drug approval is too expensive, and usually occurred as guaranteed approval for large markets. The presence of CROs is more cost-effective and allows companies to develop small drugs for niche audiences.

There are various companies involved in healthcare CRO market which includes Lambda Therapeutic Research, Ltd., PAREXEL International Corp., Pharmaceutical Product Development (PPD), LLC, Pharmaron Beijing Co., Ltd., LabCorp, and Syneos Health. Merger & acquisition, geographical expansion, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players. For instance, in July 2017, LabCorp acquired Chiltern International, Ltd., which allows the company to strengthen its position as a global life sciences company with diagnostics and drug development businesses. The acquisition supports achieving a significant global scale. Chiltern International, Ltd., becomes the company's Covance Drug Development business unit and expected to expand Covance offerings through focusing high-growth emerging and mid-market biopharma segments. The strategy of the company is to quickly offer innovative oncology medicine to a patient, that enables to improve patient outcomes. Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Asia-Pacific demonstrates considerable potentials for collaborative and outsourced R&D in drug development, biotechnology, and medical devices. The increasing government initiatives, to promote the pharmaceutical sector, as it outsources the clinical development process to specialized CRO in the region enables to expand the CRO market.

Research Methodology

The market study of the global healthcare CRO market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases such as the IBEF, IFPMA, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.

The report is intended for research organizations, dental laboratories, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Healthcare CRO Market Research and Analysis by Service
  • 2. Global Healthcare CRO Market Research and Analysis by Therapeutic Area

The Report Covers:

  • Comprehensive research methodology of the global healthcare CRO market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global healthcare CRO market.
  • Insights about market determinants which are stimulating the global healthcare CRO market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Laboratory Corporation of America Holdings (LabCorp)
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Charles River Laboratories International, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. PRA Health Sciences, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. IQVIA Holdings, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Syneos Health
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Healthcare CRO Market by Service
    • 5.1.1. Drug Discovery & Development
    • 5.1.2. Pre-Clinical Services
    • 5.1.3. Clinical Services
    • 5.1.4. Risk Management & Pharmacovigilance
    • 5.1.5. Data Management & Technology Services
    • 5.1.6. Post Marketing and Consulting Services
    • 5.1.7. Other Services (Laboratory Services and Project Management)
  • 5.2. Global Healthcare CRO Market by Therapeutic Area
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Neurology
    • 5.2.4. Respiratory Diseases
    • 5.2.5. Autoimmune Diseases
    • 5.2.6. Others (Hematology & Gynecology)

6. REGIONAL ANALYSIS

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. COMPANY PROFILES

  • 7.1. Charles River Laboratories International Inc. (CRL)
  • 7.2. Clinipace, Inc.
  • 7.3. Fisher Clinical Services, Inc.
  • 7.4. GVK Biosciences Pvt., Ltd.
  • 7.5. HCL Technologies, Ltd.
  • 7.6. ICON, PLC
  • 7.7. IQVIA Holdings, Inc.
  • 7.8. JLL Partners, LLC
  • 7.9. LabCorp (Covance)
  • 7.10. Lambda Therapeutic Research, Ltd.
  • 7.11. Medelis, Inc.
  • 7.12. Medpace, Inc.
  • 7.13. PAREXEL International Corp.
  • 7.14. Pharmaceutical Product Development, LLC
  • 7.15. Pharmaron Beijing Co., Ltd.
  • 7.16. PRA Health Sciences, Inc.
  • 7.17. Premier Research International, LLC
  • 7.18. QPS Holdings, LLC
  • 7.19. Syneos Health, Inc.
  • 7.20. Synteract, Inc.
  • 7.21. Worldwide Clinical Trials Holdings, Inc.
Back to Top
전화 문의
F A Q